Therapeutic Asset Ratings

303 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine Breast Cancer	University of Washington	P2	B (58)
Cyclophosphamide B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1	University of Washington	P2	B (58)
Cytosin-Arabinosid High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement	University of Washington	P2	B (58)
Eloxatin EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified	University of Washington	P2	B (58)
Eloxatin T-Cell/Histiocyte-Rich Large B-Cell Lymphoma	University of Washington	P2	B (58)
ETOPOSIDE T-Cell/Histiocyte Rich Large B Cell Lymphoma	University of Washington	P2	B (58)
Polatuzumab Vedotin High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement	University of Washington	P2	B (58)
SRY-BOX TRANSCRIPTION FACTOR 2 Breast Cancer	University of Washington	P2	B (58)
(+)-VINCRISTINE B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1	University of Washington	P2	B (58)
Yb-1 Breast Cancer	University of Washington	P2	B (58)
17-beta-estradiol Prostate Cancer	University of Washington	P3	B (57)
Carboplatin PSA Progression	University of Washington	P2	B (57)
Emicizumab Acquired Hemophilia A	University of Washington	P2	B (57)
FLUDEOXYGLUCOSE Her2-Receptor Negative Breast Cancer	University of Washington	P2	B (57)
FLUDEOXYGLUCOSE Metastatic Triple-Negative Breast Carcinoma	University of Washington	P2	B (57)
Mosunetuzumab Indolent B-Cell Non-Hodgkin Lymphoma	University of Washington	P2	B (57)
TESTOSTERONE CIPIONATE Prostate Adenocarcinoma	University of Washington	P2	B (57)
VIPIVOTIDE TETRAXETAN GALLIUM GA-68 Prostate Cancer	University of Washington	P2/3	B (56)
ETOPOSIDE Castration-Resistant Prostate Carcinoma	University of Washington	P2	CCC (55)
Ponatinib Lymphoblastic Lymphoma	University of Washington	P2	CCC (55)
Pumvc3-Higfbp-2 Multi-Epitope Plasmid Dna Vaccine Ovarian Carcinoma	University of Washington	P2	CCC (54)
Mitoxantrone Acute Biphenotypic Leukemia	University of Washington	P1/2	CCC (54)
17-beta-estradiol Locally Advanced Unresectable HER2-Negative Breast Carcinoma	University of Washington	P2	CCC (53)
17-beta-estradiol Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma	University of Washington	P2	CCC (53)
Abemaciclib Digestive System Neuroendocrine Neoplasm	University of Washington	P2	CCC (53)

Showing 126 to 150 of 303 assets

PreviousPage 6 of 13Next